Appellate Court Upholds Permission for Krka's Zyllt in Poland

Novo Mesto, 22 November - An appellate court in Warsaw has upheld the decision of the District Court to rejected the motion of the French pharma company Sanofi Pharma BristolMyers Squibb SNC for a temporary injunction of the sale of the drug Zyllt, which is made by Slovenia's Krka, in Poland.

The rest of this news item is available to subscribers.
The news item consists of 254 characters (without spaces) or 50 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

© STA, 2006